{"id":"NCT03931941","sponsor":"Rebiotix Inc.","briefTitle":"Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS)","officialTitle":"A Phase 3 Open-Label Clinical Study to Evaluate the Safety and Tolerability of Rebiotix RBX2660 (Microbiota Suspension) in Subjects With Recurrent Clostridium Difficile Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-07-30","primaryCompletion":"2023-07-21","completion":"2023-07-21","firstPosted":"2019-04-30","resultsPosted":"2024-08-07","lastUpdate":"2024-08-07"},"enrollment":793,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Clostridium Difficile Infection","Infection","Communicable Diseases"],"interventions":[{"type":"DRUG","name":"RBX2660","otherNames":["Microbiota suspension"]}],"arms":[{"label":"Active","type":"EXPERIMENTAL"}],"summary":"This is a prospective, multicenter, open-label Phase 3 study of a microbiota suspension of intestinal microbes. Patients who have had at least one recurrence of CDI after a primary episode and have completed at least one round of standard-of-care oral antibiotic therapy or have had at least two episodes of severe CDI resulting in hospitalization may be eligible for the study. Subjects may receive a second RBX2660 enema if they are deemed treatment failures following the initial enema per the protocol-specified treatment failure definition.","primaryOutcome":{"measure":"Safety and Tolerability of RBX2660 in Subjects With Recurrent CDI.","timeFrame":"Up to 6 months after last study treatment.","effectByArm":[{"arm":"Active Treatment","deltaMin":697,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":51,"countries":["United States","Canada"]},"refs":{"pmids":["40784972","40177588","39180326"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":87,"n":697},"commonTop":["Diarrhoea","Abdominal pain","Nausea","Abdominal distension","Urinary tract infection"]}}